Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia wit
![](https://alatorax.nyc3.cdn.digitaloceanspaces.com/images/library/interstitial-lung-disease-and-myositis-specific-and-associated-autoantibodies-clinical-manifestations-survival-and-the-performance-of-the-new-atsers-criteria-for-interstitial-pneumonia-wit_8h.jpg)
Mayra Mejía, Denisse Herrera-Bringas, Diana I. Perez-Roman, Hermes Rivero, Heidegger Mateos-Toledo, Pedro Castorena-García, Jose E. Figueroa, Jorge Rojas-Serrano.
a Interstitial Lung Disease and Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico.
b Programa de Maestría y Doctorado en Ciencias Medicas, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, Mexico.
c Hospital Universitario de Caracas, Universidad Central de Venezuela, Caracas, Venezuela.
d Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico
Archivos adjuntos